A lot of talk the past couple of days about Bavi side effects. Most likely to get everyone's mind off of forty cents per share, the failed phase III, and the impending reverse split. But Avid is looking good. Hate to think what would happen if they ever lost their customer.
For the record, how important are side effects for a drug that never gets approved for anything?
Market Data 
Markets 
AI
